A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma
- 30 June 1989
- journal article
- Published by Elsevier in Cancer Treatment Reviews
- Vol. 16, 163-167
- https://doi.org/10.1016/0305-7372(89)90037-6
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- Lymphokine-activated killer cells from normal and lymphoma subjects are cytotoxic for cells coated with antibody derivatives displaying human Fc gammaBlood, 1988
- Constant-Infusion Recombinant Interleukin-2 in Adoptive Immunotherapy of Advanced CancerNew England Journal of Medicine, 1987
- Observations on the Systemic Administration of Autologous Lymphokine-Activated Killer Cells and Recombinant Interleukin-2 to Patients with Metastatic CancerNew England Journal of Medicine, 1985
- HEPATIC METASTASES FROM COLORECTAL CARCINOMA: AN ANALYSIS OF SURVIVAL RATES AND HISTOPATHOLOGY1Anz Journal of Surgery, 1977